scholarly journals Bone Healing and Hormonal Bioassay in Patients with Long-Bone Fractures and Concomitant Head Injury

2016 ◽  
Vol 25 (4) ◽  
pp. 336-342 ◽  
Author(s):  
Fathy G. Khallaf ◽  
Elijah O. Kehinde ◽  
Sundus Hussein
Author(s):  
K. Preethi ◽  
V. Gireesh Kumar ◽  
K.B.P. Raghavender ◽  
D. Pramod Kumar ◽  
M. Lakshman

Background: Fractures associated with bone loss requires stabilization with suitable fixation devices, placement of appropriate bone grafts to fill up the bone defects and barrier membranes as space maintainers for enhanced bone regeneration. The aim of this study was to evaluate the use of beta-tricalcium phosphate (β-TCP) bone graft with collagen membrane as guided bone regeneration in long bone fractures with bone loss in dogs. Method: Six dogs with long bone fractures accompanied with bone loss in Radius-ulna, Femur and Tibia were surgically treated with suitable bone plate as internal fixation with β-TCP bone graft along with collagen membrane placed at the fracture site. Conclusion: The application of β-TCP along with collagen membrane for filling the bone defect is extremely simple, convenient and less time consuming and proved to be effective in promoting early bone healing with rapid later phase bone healing and provided osteoconductive support and early resorption.


2014 ◽  
Vol 12 (5) ◽  
pp. 477-484 ◽  
Author(s):  
Ailish Higgins ◽  
Matthew Glover ◽  
Yaling Yang ◽  
Susan Bayliss ◽  
Catherine Meads ◽  
...  

2017 ◽  
Vol 56 (2) ◽  
pp. 258-262 ◽  
Author(s):  
Jakob C. Thorud ◽  
Spencer Mortensen ◽  
Jennifer L. Thorud ◽  
Naohiro Shibuya ◽  
Yolanda Munoz Maldonado ◽  
...  

2017 ◽  
Vol 41 ◽  
pp. 142-146
Author(s):  
Yawon HWANG ◽  
Sang-Hwan HYUN ◽  
Woo-Suk HWANG ◽  
Gonhyung KIM

2017 ◽  
Vol 68 (8) ◽  
pp. 1825-1828 ◽  
Author(s):  
Paul Dan Sirbu ◽  
Razvan Tudor ◽  
Vlad Veringa ◽  
Bogdan Mihnea Ciuntu ◽  
Valentin Radu ◽  
...  

Osteoporosis is a systemic skeletal disease characterized by low bone strength, which leads to an increased risk of fracture. The primary objective of osteoporosis treatment is the prevention of fragility fractures and the secondary objective is their rapid healing if they occur. Strontium ranelate is an antiosteoporotic therapeutic agent with a double action mechanism: the increase of bone formation and the decrease of bone resorption, contributing thus to the improvement of bone healing. Preclinical studies have demonstrated the efficacy of strontium ranelate for the improvement of bone healing and bone microarhitecture, as well as of the osteointegration of implants. Some clinical cases have been reported regarding the efficacy of strontium ranelate in the healing of long bone fractures complicated by nonunion or delayed union. In the present study we have reported 2 clinical cases that demonstrate the effectiveness of the treatment with strontium ranelate (Osseor) for 3-6 months in the healing of complicated long bone fractures with delayed union. Our cases confirm the results of the open label study CL3-12911-036 (delayed union and non-union fracture study), where the treatment with 2 g/day of strontium ranelate improved healing and led to a better quality of life. Even if there are some cardiovascular contraindications, strontium ranelate is proven to reduce vertebral and non-vertebral fracture risk in osteoporosis and in the same time improves bone microarchitecture and accelerates fracture healing.


2010 ◽  
Vol 21 (1) ◽  
pp. 19-28
Author(s):  
Hiroshi Ichiyanagi ◽  
Shirou Sameshima ◽  
Jirou Ooba ◽  
Kouji Akashi ◽  
Kouichi Ootsuya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document